HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Formulation and evaluation of mini-tablets-filled-pulsincap delivery of lornoxicam in the chronotherapeutic treatment of rheumatoid arthritis.

Abstract
In this present research work, we have designed a pulsincap formulation comprising mini-tablets, which to the best of our knowledge this combination has not been reported yet. We successfully combined the advantages of mini-tablets technology to meet the optimized requirements of our pulsincap formulation. Our main aim was to target lornoxicam to treat rheumatoid arthritis as per the chronotherapeutic pattern of the disease. Directly compressing method was used to prepare mini-tablets. The drug, polymers and combine mixtures of drug and polymers was evaluated for pre-formulation testing. Prepared mini-tablets were also evaluated for physicochemical, dissolution and stability studies. From FTIR and DSC evaluation, we found no interaction between the drug and polymers used. For mini-tablets, all the physico-chemical parameters were in limit. The mini-tablets of lornoxicam were filled into an insoluble body of capsule, and its opening was sealed by plugging it with a polymer. The complete capsule body after sealing with a cap was given enteric coating. Different polymers in various concentrations were used as a plug, to identify the most suitable which gives a complete lag time of 5 hours when combined with 5% CAP coating. HPMC-K100M in 30% and sodium alginate in 40% concentrations were identified as the most suitable plugs. Our optimized pulsincap formulations releases lornoxicam after a lag time of 5 hrs and maximum portion of the drug will be released in the early morning hours. It was also found to be stable for a period of 6 months as per ICH guidelines.
AuthorsMohd Abdul Hadi, Nidagurthi Guggilla Raghavendra Rao, Avanapu Srinivasa Rao
JournalPakistan journal of pharmaceutical sciences (Pak J Pharm Sci) Vol. 28 Issue 1 Pg. 185-93 (Jan 2015) ISSN: 1011-601X [Print] Pakistan
PMID25553695 (Publication Type: Journal Article)
Chemical References
  • Alginates
  • Antirheumatic Agents
  • Hexuronic Acids
  • Powders
  • Tablets
  • Piroxicam
  • Hypromellose Derivatives
  • Glucuronic Acid
  • lornoxicam
Topics
  • Administration, Oral
  • Alginates (chemistry)
  • Antirheumatic Agents (administration & dosage, chemistry)
  • Arthritis, Rheumatoid (drug therapy)
  • Calorimetry, Differential Scanning
  • Chemistry, Pharmaceutical
  • Drug Chronotherapy
  • Drug Stability
  • Glucuronic Acid (chemistry)
  • Hexuronic Acids (chemistry)
  • Humans
  • Hypromellose Derivatives (chemistry)
  • Kinetics
  • Piroxicam (administration & dosage, analogs & derivatives, chemistry)
  • Powders
  • Solubility
  • Spectroscopy, Fourier Transform Infrared
  • Tablets

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: